Your browser doesn't support javascript.
loading
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.
Buccisano, Francesco; Palmieri, Raffaele; Piciocchi, Alfonso; Arena, Valentina; Candoni, Anna; Melillo, Lorella; Calafiore, Valeria; Cairoli, Roberto; de Fabritiis, Paolo; Storti, Gabriella; Salutari, Prassede; Lanza, Francesco; Martinelli, Giovanni; Luppi, Mario; Capria, Saveria; Maurillo, Luca; Del Principe, Maria Ilaria; Paterno, Giovangiacinto; Irno Consalvo, Maria Antonietta; Ottone, Tiziana; Lavorgna, Serena; Voso, Maria Teresa; Fazi, Paola; Vignetti, Marco; Arcese, William; Venditti, Adriano.
Afiliación
  • Buccisano F; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Palmieri R; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Piciocchi A; GIMEMA Foundation, Rome, Italy.
  • Arena V; GIMEMA Foundation, Rome, Italy.
  • Candoni A; Hematology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Melillo L; Fondazione IRCCS Casa Sollievo della Sofferenza, UO di Ematologia, San Giovanni Rotondo (FG), Italy.
  • Calafiore V; Ospedale Ferrarotto, Catania, Italy.
  • Cairoli R; Ospedale Niguarda Ca Granda, Milan, Italy.
  • de Fabritiis P; Ospedale S. Eugenio, Rome, Italy.
  • Storti G; Azienda Ospedaliera S.G. Moscati, Avellino, Italy.
  • Salutari P; Azienda USL di Pescara, Pescara, Italy.
  • Lanza F; Ospedale S. Maria delle Croci, Ravenna, Italy.
  • Martinelli G; Istituto Tumori della Romagna, Meldola, Italy.
  • Luppi M; Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • Capria S; Ematologia, Dipartimento di Scienza Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università degli studi di Modena e Reggio Emilia, Modena, Italy.
  • Maurillo L; Dipartimento di Biotecnologie Cellulari ed Ematologia, Ematologia Università degli Studi Sapienza, Rome, Italy; and.
  • Del Principe MI; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Paterno G; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Irno Consalvo MA; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Ottone T; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Lavorgna S; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Voso MT; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Fazi P; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Vignetti M; GIMEMA Foundation, Rome, Italy.
  • Arcese W; GIMEMA Foundation, Rome, Italy.
  • Venditti A; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
Blood Adv ; 6(8): 2510-2516, 2022 04 26.
Article en En | MEDLINE | ID: mdl-34731884

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante Homólogo Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante Homólogo Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Italia